Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00171236

Enrollment

Registered

2005-09-15

Start date

2001-10-31

Completion date

2005-03-31

Last updated

2011-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heterozygous Familial Hypercholesterolemia, Mixed Dyslipidemia

Keywords

Heterozygous familial hypercholesterolemia, mixed dyslipidemia

Brief summary

The purpose of the study is to assess the safety and efficacy of fluvastatin in children diagnosed with heterozygous familial hypercholesterolemia

Interventions

DRUGFluvastatin

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

10 Years to 16 Years

Healthy volunteers

Inclusion criteria

* 10-16 years old Heterozygous familial hypercholesterolemia

Exclusion criteria

* Homozygous familial hypercholesterolemia Pregnant or lactating females Major surgery during the six month prior study Other protocol defined inclusion and

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026